$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded on July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Fore HenriettaDirector24,000734,400shares bought: 18,000 / shares sold: 0 STRONG BUYAug 11 20172 months ago
GALA RENEE DSVP, Chief Financial Officer214,5476,565,138shares bought: 99,000 / shares sold: -35,983 STRONG BUYAug 22 20172 months ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc149,3424,569,865shares bought: 99,000 / shares sold: -71,166 BUYAug 22 20172 months ago
HEGDE SHARATHCHANDRA SSVP, Research160,1374,900,192shares bought: 114,000 / shares sold: -26,028 STRONG BUYAug 22 20172 months ago
MALKIEL BURTON GDirector47,5711,455,673shares bought: 42,000 / shares sold: 0 STRONG BUYAug 14 20172 months ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer213,1806,523,308shares bought: 103,000 / shares sold: -20,402 STRONG BUYAug 23 20172 months ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng152,3204,660,992shares bought: 114,000 / shares sold: -25,241 STRONG BUYAug 22 20172 months ago
Shafer Bradford JEVP, Gen. Counsel, Secretary134,3274,110,406shares bought: 124,000 / shares sold: -129,243 SELLSep 08 20172 months ago
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy20,000612,000shares bought: 20,000 / shares sold: 0 BUYAug 03 20173 months ago
WHITESIDES GEORGE MDirector4,000122,400shares bought: 16,000 / shares sold: 0 STRONG BUYAug 14 20172 months ago
Winningham Rick EChief Executive Officer866,37726,511,136shares bought: 318,000 / shares sold: -57,084 STRONG BUYAug 11 20172 months ago
WORBOYS PHILIP DSVP, Translational Science164,6325,037,739shares bought: 114,000 / shares sold: -27,715 STRONG BUYAug 22 20172 months ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 08 2017TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...SellS30.7714,670451,350134,327149 K to 134.3 K (-9.85 %)
Aug 23 2017TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...BuyP26.344,000105,359213,180209.2 K to 213.2 K (+1.91 %)
Aug 22 2017TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF27.405,502150,755164,632170.1 K to 164.6 K (-3.23 %)
Aug 22 2017TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...Payment of ExerciseF27.407,079193,965148,997156.1 K to 149 K (-4.54 %)
Aug 22 2017TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...Payment of ExerciseF27.405,013137,356152,320157.3 K to 152.3 K (-3.19 %)
Aug 22 2017TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...Payment of ExerciseF27.405,820159,468209,180215 K to 209.2 K (-2.71 %)
Aug 22 2017TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchPayment of ExerciseF27.405,176141,822160,137165.3 K to 160.1 K (-3.13 %)
Aug 22 2017TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...Payment of ExerciseF27.407,064193,554149,342156.4 K to 149.3 K (-4.52 %)
Aug 22 2017TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...Payment of ExerciseF27.406,752185,005214,547221.3 K to 214.5 K (-3.05 %)
Aug 14 2017TBPHTheravance Biophar ...WHITESIDES GEORGE MDirectorBuyP24.694,00098,7644,0000 to 4 K
Aug 14 2017TBPHTheravance Biophar ...MALKIEL BURTON GDirectorBuyP24.5915,000368,81615,0000 to 15 K
Aug 14 2017TBPHTheravance Biophar ...MALKIEL BURTON GDirectorBuyP24.5915,000368,85547,57132.6 K to 47.6 K (+46.05 %)
Aug 11 2017TBPHTheravance Biophar ...Fore HenriettaDirectorBuyP23.996,000143,93224,00018 K to 24 K (+33.33 %)
Aug 11 2017TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...BuyP24.5010,000245,000866,377856.4 K to 866.4 K (+1.17 %)
Aug 03 2017TBPHTheravance Biophar ...SULIMAN SHEHNAAZSVP, Corp Dev & Str ...Option ExerciseA31.93170,0005,428,100170,000

View all Theravance Biopharma, Inc. insider transactions.